CTSA INFRASTRUCTURE FOR CLINICAL TRIALS

CTSA 临床试验基础设施

• 批准号: 8365224
• 负责人: Philip Greenland
• 金额: $ 164.87万
• 依托单位: NORTHWESTERN UNIVERSITY AT CHICAGO
• 依托单位国家: 美国
• 财政年份: 2011
• 资助国家: 美国
• 起止时间: 2011-05-01 至 2012-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8365224
• 关键词: Clinical Sciences; Clinical Trials; Research Infrastructure; Translational Research; multidisciplinary; programs

This subproject represents an estimate of the percentage of the CTSA funding that is being utilized for a broad area of research (AIDS research, pediatric research, or clinical trials). The Total Cost listed is only an estimate of the amount of CTSA infrastructure going towards this area of research, not direct funding provided by the NCRR grant to the subproject or subproject staff. The overall goal of this CTSA program is to create an integrated, efficient, and proactive academic home to promote, facilitate, and transform clinical and translational research at Northwestern University (NU) and its affiliated clinical institutions. The program includes participation by six NU schools and all four of its affiliated hospitals. The focal point of this application is the new Northwestern University Clinical and Translational Sciences (NUCATS) Institute, a physical and intellectual home for its leaders, member faculty, and research trainees. The major principle driving this program of teaching, research development, and infrastructure is that an integrated and focused research organization can propel the translation of research findings into mproved patient care and population health more rapidly and effectively than the decentralized approaches to clinical and translational research that now exist in most academic institutions. The NU CTSA application has 4 goals: 1. Provide new, broad-based, and coordinated leadership to accelerate translation of ideas into health-care solutions within the Northwestern University community and beyond by systematically studying and promoting multidisciplinary research interactions in the context of new research teams and, in so doing, to gain fundamental insights into the process of clinical/translational collaboration 2. Create and support a new and expanded set of research and training resources (tools) that will support new discoveries, new technology development, and translational team-based research 3. Educate and encourage a broad range of scientists.and health care providers to study and solve important health problems in a team-based environment at the interfaces between fundamental science, clinical medicine, and the community 4. Evaluate the impact of the new tools and new collaborations that we have developed in order to continuously improve our outcomes. The faculty leaders chosen to direct the Institute and its functional components have the experience, authority, and committed time to administer the new home for clinical and translational research. The Program benefits from an outstanding research environment and tremendous institutional support.

该子项目代表了 CTSA 资金百分比的估计 被用于广泛的研究领域（艾滋病研究、儿科研究或 临床试验）。 列出的总成本只是 CTSA 金额的估计值 该研究领域的基础设施，而不是直接资助 NCRR 向子项目或子项目人员提供的补助金。 该 CTSA 计划的总体目标是创建一个综合、高效和积极主动的学术家园，以促进、促进和转变西北大学 (NU) 及其附属临床机构的临床和转化研究。该计划包括六所国立大学学校及其所有四家附属医院的参与。该应用程序的重点是新的西北大学临床和转化科学研究所 (NUCATS)，这是其领导者、成员教员和研究实习生的物质和智力家园。推动这一教学、研究开发和基础设施计划的主要原则是，与分散的临床和转化研究方法相比，一个综合且专注的研究组织可以更快、更有效地推动研究成果转化为改善的患者护理和人口健康。现在大多数学术机构都存在。 NU CTSA 申请有 4 个目标： 1. 提供新的、基础广泛且协调的领导力，通过在新的背景下系统地研究和促进多学科研究互动，加速将想法转化为西北大学社区内外的医疗保健解决方案。 2. 创建并支持一套新的和扩展的研究和培训资源（工具），以支持新发现、新技术开发和转化基于团队的研究3. 教育和鼓励广大科学家和医疗保健提供者在基础科学、临床医学和社区之间的团队环境中研究和解决重要的健康问题 4. 评估新工具的影响以及我们为了不断改善我们的成果而开发的新合作。被选来指导研究所及其职能部门的教职领导拥有丰富的经验、权威和投入的时间来管理临床和转化研究的新家。该计划受益于出色的研究环境和巨大的机构支持。